StonvexLoading…
StonvexStonvexStonvexCore line items from EBS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $156.10M | $742.90M | $594.20M | $363.10M |
Operating Income | $10.50M | $100.10M | $128.00M | $51.50M |
Net Income | $6.80M | $52.60M | $107.20M | $-12.00M |
EPS (Diluted) | $0.07 | $0.93 | $1.89 | $0.99 |
Total Assets | $1.32B | $1.32B | $1.46B | $1.42B |
Total Liabilities | $797.30M | $796.00M | $878.50M | $880.90M |
Cash & Equivalents | $160.30M | $205.40M | $245.50M | $267.30M |
Free Cash Flow OCF − CapEx | $-36.20M | $156.80M | $83.00M | $88.70M |
Shares Outstanding | 51.80M | 52.10M | 52.70M | 53.70M |